Home›Search›Current Pharmaceutical Design

Current Pharmaceutical Design

Bentham Science Publishers · United Arab Emirates · Est. 1840

ISSN1381-6128eISSN1873-4286

SJR Q2✓ WOS SCIE✓ Scopus / SJR

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (3 more)+18

Total96

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

268

days submission → published

measured · last 20 articles · accept 81d

SJR Rank

Top 50% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.

SJR Scorei

0.632

H-Indexi

205

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

0.624

Total Worksi

11,477

Total Citationsi

390,082

2yr Mean Citednessi

2.36

Open Impact Factor alternative

Retractions

Source: Retraction Watch

Aims & Scope

Bentham aims to inform about the latest scientific developments in the area of illegal and prescription drugs and addiction. Topics covered include drug science, genetics, the latest academic research and information on addiction treatment. The mission is to educate the public and professionals about the science of drugs and drug addiction, including information regarding the causes of drug addiction and the associated consequences, as well as addiction treatment. They cover the latest scientific revelations regarding drugs and drug addiction by monitoring scientific journals dealing with this subject, aiming to educate the public using simple and easy to understand language.

General Information

Country / RegionUnited Arab Emirates

Primary LanguageEnglish

1st Year Published1840

FrequencyForty-Six No. A Year, 2016-

StatusActive (last: 2026)

Total Publications11,477

Publisher OrgBentham Science Publishers

Visit Journal Website

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/12 · 50%

✅

Do you know the journal / publisher?

Bentham Science Publishers

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1381-6128 / 1873-4286

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

588

17k

2019

741

14k

2020

351

3.8k

2021

317

3.3k

2022

301

2.3k

2023

327

1.7k

2024

327

581

2025

248

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Drug DiscoveryQ2

PharmacologyQ2

Subject Classification

Web of Science Categories

Pharmacology & Pharmacy

Scopus Categories

PharmacologyDrug Discovery

Research Topics (OpenAlex)

Computational Drug Discovery MethodsNanoparticle-Based Drug DeliveryRNA Interference and Gene DeliveryAdvanced Drug Delivery SystemsMonoclonal and Polyclonal Antibodies ResearchLipoproteins and Cardiovascular HealthTryptophan and brain disordersSynthesis and biological activityReceptor Mechanisms and SignalingCholinesterase and Neurodegenerative Diseases

Frequently asked questions about Current Pharmaceutical Design

Is Current Pharmaceutical Design a predatory journal?

PubScope has no integrity flags on record for Current Pharmaceutical Design: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 96/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Current Pharmaceutical Design?

Current Pharmaceutical Design is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 2.36.

Is Current Pharmaceutical Design indexed in Scopus and Web of Science?

Current Pharmaceutical Design is indexed in Web of Science, Scopus.